SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences trades jubilantly on acquiring 100% stake in Gujarat Agrofarm

21 Nov 2014 Evaluate

Hester Biosciences is currently trading at Rs. 420.25, up by 17.55 points or 4.36% from its previous closing of Rs. 402.70 on the BSE.

The scrip opened at Rs. 420.00 and has touched a high and low of Rs. 423.25 and Rs. 405.00 respectively. So far 1977 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 471.70 on 11-Sep-2014 and a 52 week low of Rs. 78.10 on 05-Feb-2014.

Last one week high and low of the scrip stood at Rs. 423.25 and Rs. 363.00 respectively. The current market cap of the company is Rs. 342.57 crore.

The promoters holding in the company stood at 53.81% while Institutions and Non-Institutions held 0.14% and 46.05% respectively.

Hester Biosciences has acquired 100% share holding of Gujarat Agrofarm for Rs 52.50 lakh. Gujarat Agrofarm, a company located in Gujarat, is involved in the manufacturing of growth media.

This backward integration by Hester aims at securing for itself a source of growth media used in the production of vaccines.  The acquisition would enable Hester in saving over Rs 1.50 crore annually towards growth media procurement costs.

Hester Biosciences is a 100% biotech company producing animal biological. Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

 

Hester Biosciences Share Price

1649.65 11.45 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×